Older adults: Should the paradigm shift from standard therapy?
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Oncology
Reference10 articles.
1. FLT3 mutation and response to intensive chemotherapy in young adult and elderly patients with normal karyotype;Beran;Leukemia Research,2004
2. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome;Kantarjian;Cancer,2006
3. Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia;Estey;Leukemia,1989
4. Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study;Anderson;Blood,2002
5. The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations;Appelbaum;British Journal of Haematology,2006
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Low dose of homoharringtonine and cytarabine-based priming induction regimens for patients with de novo acute myeloid leukemia and high-risk myelodysplastic syndrome aged over 70 years;Hematology;2021-01-01
2. American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults;Blood Advances;2020-08-06
3. Outcome of elderly patients after failure to hypomethylating agents given as frontline therapy for acute myeloid leukemia: Single institution experience*;American Journal of Hematology;2017-06-05
4. Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia;Oncotarget;2015-01-31
5. Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study;Leukemia & Lymphoma;2015-01-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3